Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.22 - $0.62 $66,000 - $186,000
300,000 Added 20.46%
1,766,384 $494,000
Q4 2022

Feb 14, 2023

BUY
$0.38 - $1.91 $158,603 - $797,191
417,378 Added 39.79%
1,466,384 $615,000
Q3 2022

Nov 14, 2022

BUY
$1.46 - $2.38 $609,877 - $994,183
417,724 Added 66.17%
1,049,006 $1.69 Million
Q2 2022

Aug 15, 2022

SELL
$1.98 - $5.66 $198,000 - $566,000
-100,000 Reduced 13.67%
631,282 $1.27 Million
Q1 2022

May 16, 2022

SELL
$4.52 - $12.9 $562,134 - $1.6 Million
-124,366 Reduced 14.53%
731,282 $3.91 Million
Q4 2021

Feb 14, 2022

BUY
$9.01 - $14.1 $7.71 Million - $12.1 Million
855,648 New
855,648 $9.78 Million

Others Institutions Holding SNCE

About Science 37 Holdings, Inc.


  • Ticker SNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 116,348,000
  • Description
  • Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...
More about SNCE
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.